Abstract
Background Pediatricians lack tools to support families at home for the promotion of childhood sleep. We are using the Multiphase Optimization Strategy (MOST) framework to guide the development of a mobile health platform for childhood sleep promotion.
Purpose Under the preparation phase of the MOST framework, to demonstrate feasibility of a mobile health platform towards treating children with insufficient sleep.
Methods Children aged 10-12y were enrolled (Study #1: N=30; Study #2: N=43). Participants wore a sleep tracker to measure sleep duration. Data were retrieved by a mobile health platform, programmed to send introductory messages during run-in (2 weeks) and goal achievement messages during intervention (7 weeks) periods. In study #1, participants were randomized to control, gain-framed incentive or loss-framed incentive arms. In study #2, participants were randomized to control, loss-framed incentive, normative feedback or loss-framed incentive plus normative feedback arms.
Results In study #1, 1,514 nights of data were captured (69%) and sleep duration during the intervention was higher by an average of 21 (95% CI: -8, 51) and 34 (95% CI: 7, 61) minutes per night for the gain-framed and loss-framed arms, respectively, compared to controls. In study #2, 2,689 nights of data were captured (81%), with no major differences in average sleep duration between the control and the loss-framed or normative feedback arms.
Conclusion We have developed and deployed a mobile health platform that can capture sleep data and remotely communicate with families. Promising candidate intervention components will be further investigated under the optimization phase of the MOST framework.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03263338 and NCT03426644
Funding Statement
Study #1 was supported by an NIH/NHLBI Career Development Award K01HL123612 and internal awards from CHOP (Pediatric Development Funds and the Metabolism, Nutrition and Physical Development Research Affinity Group). Study #2 was supported by an NIH/NHLBI Career Development Award K01HL123612 and in part by Grant Number UL1TR001878 from the National Center for Advancing Translational Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Science or the National Institutes of Health. Study #2 was also supported in part by the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania. Ariel A. Williamson was supported by a Eunice Kennedy Shriver National Institute of Child Health and Human Development Career Development Award K23HD094905 and by the Sleep Research Society Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The CHOP Institutional Review Board approved both studies in this manuscript (study #1: 17-014078; study #2: 17-014700).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data can be made available upon request to the corresponding author (JM). Access to the data will require a data sharing agreement with the Children's Hospital of Philadelphia.
